ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,788Medicare Part D Prescriptions Filled, Including Refills

Rank: 264 out of 2588

$578K Total Retail Price of All Prescriptions

Rank: 356 out of 2588

586 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 586 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

17% of this provider’s 586 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 10,292 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 674 623 1 1
AMLODIPINE BESYLATE 568 511 2 4
LISINOPRIL 519 481 3 3
LEVOTHYROXINE SODIUM 488 452 4 2
WARFARIN SODIUM 412 385 5 10
HYDROCODONE-ACETAMINOPHEN 320 282 S3 6 7
HYDROCHLOROTHIAZIDE 299 283 7 13
METOPROLOL TARTRATE 263 246 8 9
FUROSEMIDE 235 192 9 5
OMEPRAZOLE 232 211 10 6
METFORMIN HCL 214 162 11 8
TRICOR 191 163 12 122
POTASSIUM CHLORIDE 189 149 13 15
ZOLPIDEM TARTRATE 167 135 14 24
ENALAPRIL MALEATE 166 155 15 31
ATENOLOL 164 152 16 14
ALENDRONATE SODIUM 164 155 16 21
HYDRALAZINE HCL 154 141 18 53
CARVEDILOL 150 130 19 20
METOPROLOL SUCCINATE 136 127 20 12
CITALOPRAM HBR 135 133 21 27
LOSARTAN POTASSIUM 125 106 22 17
PANTOPRAZOLE SODIUM 124 108 23 28
ATORVASTATIN CALCIUM 123 105 24 11
PRAVASTATIN SODIUM 116 115 25 16
TRIAMTERENE-HCTZ 113 97 26 46
TRAMADOL HCL 112 102 27 19
LOVASTATIN 101 90 28 34
GABAPENTIN 100 83 29 18
ZETIA 99 97 30 69
SPIRONOLACTONE 94 75 31 58
GLIMEPIRIDE 92 74 32 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 85 65 33 35
DONEPEZIL HCL 85 82 33 22
CLOPIDOGREL 81 81 35 30
FENTANYL 78 66 S2 36 78
PLAVIX 77 76 37 43
AZITHROMYCIN 74 60 38 45
DILTIAZEM 24HR CD 73 67 39 98
CIPROFLOXACIN HCL 72 63 40 82
CRESTOR 72 58 40 25
FENOFIBRATE 71 53 42 64
BUMETANIDE 69 55 43 117
LEVOFLOXACIN 65 55 44 77
JANUVIA 60 47 45 60
ALLOPURINOL 57 54 46 33
TAMSULOSIN HCL 56 31 47 23
NAMENDA 55 50 48 32
CYCLOBENZAPRINE HCL 54 38 R 49 87
POLYETHYLENE GLYCOL 3350 54 36 49 55
SYMBICORT 53 40 51 129
GLIPIZIDE ER 51 51 52 73
IPRATROPIUM-ALBUTEROL 50 49 53 104
DIGOXIN 50 43 53 38
KLOR-CON M10 50 50 53 139
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 18, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.